Genmab — April 2023

[Bulder]

Novo har fået på hatten hele dagen. Forstærkes nu.

[E_L]

ASCO abstract titles are out for those interested https://meetings.asco.org/abstracts-presentations

[Bulder]

Us healthcare er mørkerødt sammen med NBI.

[Teller]

Nu vil det Biden taler om jo næppe ramme nye midler... Det har altid været "hverdags medicin" der har stået for skud

[Bulder]

Jeg heller ikke så meget på, at genmab bliver ramt (eller Novo for den sags skyld), men det får altid en kurseffekt, hver gang emnet kommer på bane. Det er mere valgflæsk end realiteter.

[Bulder]

… tror …

[JKY_VH]

Ja det er set før især når Bernie Sanders har givet den gas.

[bikube]

Bernie har jo lige meddelt, at han ikke stiller op til valget denne gang, men han støtter Bidens kandidatur.

[JKY_VH]

I know, men det var hans tidligere retorik jeg referede til;-)

[Helge_LarsenPI-redaktør]

Godmorgen

[bibob]

God morgen.

[Stroka]

God morgen

[E_L]

I don't the full abstract was posted yet: Tisotumab vedotin (TV) in squamous cell carcinoma of head and neck (SCCHN): interim analysis from innovaTV 207 https://aacrjournals.org/cancerres/article/83/8_Supplement/CT164/725551

[E_L]

i wonder if they will also try this dose adjustment now in the cervical cancer population. not sure how difficult this is in an already approved dosing regimen

[E_L]

Seagen reports later today. possibly the last time before pfizer takes over? See if they are on track for more data updates in H2, as anticipated

[E_L]

sanofi Q1 23 - Sarclisa
sales were €87 million -that still doesn't look like huge competition
so far

[Bulder]

Still not sc. As far as I can see. Study started last year. https://clinicaltrials.gov/ct2/show/NCT05405166

[E_L]

no; they have it in their Expected submission timeline in '2025 and beyond' https://www.sanofi.com/dam/jcr:a47dcb49-3067-44bc-9cd1-dc1fd0094b66/2023_04_27_Sanofi_Q1_2023_Results_Presentation.pdf

[Bulder]

Oh, by that time dara patent has run out almost.

[E_L]